GlobeNewsWire
24 Dec 2025, 15:44 UTC · 39w ago
Verdict
Headline leans bearish. We score QURE −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
The FDA notified uniQure that data for its Huntington’s disease gene therapy (AMT-130) was insufficient to support a Biologics License Application (BLA) submission.
So whatThe loss of a viable path to regulatory approval for a primary product candidate is a fundamental negative for a biotech company's valuation.
More negative than 99% of claims this week
The timing for the BLA submission of AMT-130 is now unclear due to the FDA's disagreement with the adequacy of Phase I/II study data.
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 95% of claims this week
Law firm Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations by uniQure following a 50% stock price drop.
More negative than 78% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company's stock fell over 50% after the FDA indicated insufficient evidence for its AMT-130 BLA submission, leading to a securities law investigation.
More negative than 85% of ticker scores this week
The company is the subject of a securities fraud class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
3h ago
+58.5%
Price is moving against the score
$38.32 vs $24.18 close before publication (Dec 23) · not market-adjusted
QURE chart →
